Naturalendo Tech내츄럴엔도텍
168330 · KOSDAQ · ₩168330 · 내츄럴엔도텍
- Market cap
- ₩66B
- Enterprise value
- ₩70B
- P/E
- —
- P/B
- 2.8×
- Dividend yield
- 0.0%
- ROE
- −6.9%
- Net margin
- −7.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−49.0% from the high
₩1,668Today: ₩2,070 – ₩2,130₩4,100
Returns
- 1W−1.6%
- 1M−11.6%
- 3M+12.5%
- 6M−22.6%
- YTD−32.6%
- 1Y−12.2%
- Volume today
- 5,508
- 0.5× the 20-day average
- Traded today
- ₩12M
- Listed shares
- 31,754,900
- EPS (12 months)
- −₩51
- Earnings yield −2.5%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 35 of 100 (50 is a normal day for this stock).
- MomentumWeak-10.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Naturalendo Tech stock overview
Naturalendo Tech (내츄럴엔도텍, KRX: 168330) is listed on KOSDAQ, in the Biotech & Pharma sector. Naturalendo Tech is a Korean healthcare company that develops natural-ingredient bio research for anti-aging and health improvement. Its shares closed at ₩2,090 on Oct 27, 2026, up 0.72% on the day, giving it a market value of ₩66B.
Key facts
- Market cap
- ₩66B
- Sector
- Biotech & Pharma
- Latest price change
- +0.72%
- As of
- Oct 27, 2026
- Main business
- Naturalendo Tech is a Korean healthcare company that develops natural-ingredient bio research for anti-aging and health improvement.
Quick answers about Naturalendo Tech
- What does Naturalendo Tech do?
- Naturalendo Tech is a Korean healthcare company that develops natural-ingredient bio research for anti-aging and health improvement. It supplies functional health foods and cosmeceutical products, including the NEEDIN health food line, the NEEDLY beauty line, and a Hericium-free plant extract line for menopausal women, and through its subsidiary Endoderma it develops and produces microneedle patches based on transdermal drug delivery systems. The company operates production facilities in Icheon and Osong, Korea, and sells products domestically and overseas, with exports to Canada, the United States, and Southeast Asia.
- What is the market cap of Naturalendo Tech?
- The market capitalisation of Naturalendo Tech was ₩66B at the close on Oct 27, 2026.
- Who are the largest shareholders of Naturalendo Tech?
- According to the latest official filings, the largest reported holders are Seo-heung (33.71%, as of May 12, 2025); Kim Jae-su (3.01%, as of May 9, 2025); Yang Joo-hwan (2.20%, as of May 12, 2025).
- When is the next earnings report from Naturalendo Tech?
- Korean companies rarely announce results dates in advance. Based on when Naturalendo Tech filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Naturalendo Tech?
- Yes. The National Pension Service held 0.10% of Naturalendo Tech shares as of Dec 31, 2017.
Company profile
Naturalendo Tech is a Korean healthcare company that develops natural-ingredient bio research for anti-aging and health improvement. It supplies functional health foods and cosmeceutical products, including the NEEDIN health food line, the NEEDLY beauty line, and a Hericium-free plant extract line for menopausal women, and through its subsidiary Endoderma it develops and produces microneedle patches based on transdermal drug delivery systems. The company operates production facilities in Icheon and Osong, Korea, and sells products domestically and overseas, with exports to Canada, the United States, and Southeast Asia.
Written by AI from the company's latest annual report.
- Korean name
- 내츄럴엔도텍
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 김희도
- Founded
- May 2001
- Listed
- Oct 2013
- Listed shares
- 31,754,900
- Fiscal year ends
- Month 12
- Website
- www.naturalendo.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Amended: Half-year report (Jun 2026)Aug 18, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Annual general meeting resultsMar 24, 2026
- Audit report submittedMar 16, 2026
Titles in Korean until English translations are added.
Also known as: Naturalendo Tech / 내츄럴엔도텍 / 168330 / KRX:168330
Source: KRX statistical information